Table 1.
Patient demographics
| N (%) | Mean (SD) | Median(range) | |
|---|---|---|---|
|
| |||
| Sample size | 50 | ||
|
| |||
| Number of observations | 85 | ||
|
| |||
| Gender | |||
| Male | 20 (40) | ||
| Female | 30(60) | ||
|
| |||
| Race | |||
| Black/African American | 9 (18) | ||
| White | 36 (72) | ||
| Hispanic/Latino | 5 (10) | ||
|
| |||
| Clinical sites | |||
| JHU | 15 (30) | ||
| MUSC | 11 (22) | ||
| PENN | 6 (12) | ||
| ROCH | 8(16) | ||
| USC | 10(20) | ||
|
| |||
| Baseline Age (years) | 75 (7.76) | 76 (53–89) | |
|
| |||
| Baseline Weight (Ib) Without 4 missing values |
159 (37.08) | 147 (107–245) | |
|
| |||
| Baseline Height (In) Without 9 missing values |
64 (4.45) | 64 (57–72) | |
|
| |||
| Sertraline dose administered (mg) | 92.47 (18.62) | 100 (25–100) | |
|
| |||
| Sertraline concentrations (ng mL−1) Without 5 BQL values |
62.94 (47.62) | 49 (9–229) | |